Asia / JAPAN
To continue to view the full report
Buy this company's report, or subscribe to a plan.
Company Overview
Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. It operates through the following divisions: Cardiac Rhythm Management, Electrophysiology and Ablation, Cadiovascular and Vascular Surgery, and Transvascular Intervention. The Cardiac Rhythm Management division provides implantable devices to treat arrhythmias. The Electrophysiology and Ablation division offers disposable catheter devices with electrodes for the diagnosis and treatment of arrhythmias. The Cadiovascular and Vascular Surgery division handles vascular grafts to treat blood vessels. The Transvascular Intervention division deals with devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities, and congenital cardiac diseases. The company was founded by Keisuke Suzuki and Takeshi Masumoto on February 6, 1981 and is headquartered in Tokyo, Japan.
Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. It operates through the following divisions: Cardiac Rhythm Management, Electrophysiology and Ablation, Cadiovascular and Vascular Surgery, and Transvascular Intervention. The Cardiac Rhythm Management division provides implantable devices to treat arrhythmias. The Electrophysiology and Ablation division offers disposable catheter devices with electrodes for the diagnosis and treatment of arrhythmias. The Cadiovascular and Vascular Surgery division handles vascular grafts to treat blood vessels. The Transvascular Intervention division deals with devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities, and congenital cardiac diseases. The company was founded by Keisuke Suzuki and Takeshi Masumoto on February 6, 1981 and is headquartered in Tokyo, Japan.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Health Care Equipment & Services |
| Sub Industry | Surgical & Medical Instruments |
| Country | JAPAN |
| Employees | 1,304 |
| Reporting Unit | Billions |
| Primary Exchange | FRA TYO |
| Instrument Type | Equity |
| Website | http://www.jll.co.jp |
| Wright ID | C392PSNW2 |
Key Metrics
| Current price | $1,558.00 |
| Market cap | $109.32 B |
| P/E ratio | 12.14 |
| 52-week perf. | +12.5% |
| Common shares | 70.2 M |
| Closely held | 18.4 M |
| Share type | Common |
| Quality rating | CAA8 |
| Dividend yield | 3.47% |
Recent stock performance
| 1 Week | -2.0% |
| 4 Week | +4.8% |
| 13 Week | +0.9% |
Officers
| President & Chief Executive | Keisuke Suzuki (Rep) |
| Vice President & Chief Operating Officer | Atsuhiro Suzuki (Rep) |
Address
2-2-20 Higashi-Shinagawa
SHINAGAWA-KU, Tokyo-to
JAPAN
140-0002
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.